Company

Site Therapeutics

Biotechnology Research 15 employees

Employees: 15
Contacts: 4
Emails: 4
Phones: 1

Site Therapeutics Overview

Industry: Biotechnology Research
Employees: 15
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

About Site Therapeutics

Site Therapeutics aims to map—down to the nucleotide—the genetic determinants driving immune cell function in human health and disease. Leveraging technology developed in the Marson Lab at UCSF/Gladstone, we will conduct high-throughput functional genomics in human cells to build a blueprint for fine-tuned control of immune cell function. This detailed map will lead to the development of new therapeutics across modalities for a range of immune-related conditions. We are backed by The Column Group, a leading life sciences venture capital firm.

Site Therapeutics Contact Details

People in AeroLeads: 4
With contact data: 4
Email contacts: 4; 100.0% coverage
Phone contacts: 1; 25.0% coverage

Site Therapeutics Org Chart

Sample employees and titles

Name	Title	Location	Contact
Jessica T. Cortez, Phd	Principal Scientist at Site Therapeutics	San Francisco, California, United States	Email
Manu Kumar	Principal Computational Scientist	San Francisco Bay Area, United States	Email Phone
Scott Rosenberg	Principal Scientist, Site Therapeutics	Sunnyvale, California, United States	Email
Kyle Simonetta, Ph.d.	SVP, Research at Site Therapeutics	South San Francisco, California, United States	Email